SB2933Introduced in the Senate
Relating To Health Care Costs.
Introduced by Angus McKelvey, District 6
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Establishes the Prescription Drug Affordability Board within the Department of Health to conduct affordability reviews on high-cost prescription drugs and establish upper payment limits under certain circumstances. Establishes out-of-pocket maximums for prescribed insulin, asthma inhalers, and epinephrine auto-injectors. Prohibits copayment adjustment programs. Requires health insurers, mutual benefit societies, and health maintenance organizations to comply with certain affordability measures. Requires annual reports to the Legislature. Requires adoption of rules by the Affordability Board and Insurance Commissioner. Appropriates funds.
Where it stands
The committee on CPN deferred the measure.
February 18, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
Bill history
Introduced.
Passed First Reading.
Referred to HHS/CPN, WAM/JDC.
The committee(s) on HHS/CPN has scheduled a public hearing on 02-17-26 9:45AM; Conference Room 229 & Videoconference.
The committee(s) on HHS/CPN deferred the measure until 02-18-26 10:06AM; Conference Room 229 & Videoconference.
The committee on HHS deferred the measure.
The committee on CPN deferred the measure.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.